Lv4
510 积分 2023-09-05 加入
Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders
15天前
已完结
Placebo-controlled study in neuromyelitis optica—Ethical and design considerations
15天前
已完结
Rituximab Exhibits Altered Pharmacokinetics in Patients With Membranous Nephropathy
15天前
已完结
Rituximab Therapy in Idiopathic Membranous Nephropathy
15天前
已完结
Urinary rituximab loss and rate of treatment failure in membranous nephropathy
1个月前
已完结
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting
1个月前
已完结
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG–Positive NMOSD
1个月前
已完结
Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis
1个月前
已完结
Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum
1个月前
已完结
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting
1个月前
已完结
皖公网安备34019202002308
